12-22055532-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_018686.6(CMAS):āc.481A>Gā(p.Ile161Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,460,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018686.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMAS | NM_018686.6 | c.481A>G | p.Ile161Val | missense_variant | 3/8 | ENST00000229329.7 | NP_061156.1 | |
CMAS | NR_135117.2 | n.567A>G | non_coding_transcript_exon_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CMAS | ENST00000229329.7 | c.481A>G | p.Ile161Val | missense_variant | 3/8 | 1 | NM_018686.6 | ENSP00000229329 | P1 | |
CMAS | ENST00000534981.5 | c.481A>G | p.Ile161Val | missense_variant, NMD_transcript_variant | 3/7 | 1 | ENSP00000446239 | |||
CMAS | ENST00000538498.1 | c.4A>G | p.Ile2Val | missense_variant | 2/4 | 3 | ENSP00000440605 | |||
CMAS | ENST00000535610.5 | c.*71A>G | 3_prime_UTR_variant, NMD_transcript_variant | 2/5 | 5 | ENSP00000439404 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460324Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726328
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.481A>G (p.I161V) alteration is located in exon 3 (coding exon 3) of the CMAS gene. This alteration results from a A to G substitution at nucleotide position 481, causing the isoleucine (I) at amino acid position 161 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.